Details for New Drug Application (NDA): 086399
✉ Email this page to a colleague
NDA 086399 describes THEOLAIR, which is a drug marketed by 3M and Medicis and is included in six NDAs. Additional details are available on the THEOLAIR profile page.
The generic ingredient in THEOLAIR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOLAIR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 086399
| Tradename: | THEOLAIR |
| Applicant: | Medicis |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086399
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
